GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qinghai Spring Medicinal Resources Technology Co Ltd (SHSE:600381) » Definitions » EV-to-FCF

Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) EV-to-FCF : 70.97 (As of Dec. 12, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Qinghai Spring Medicinal Resources Technology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Qinghai Spring Medicinal Resources Technology Co's Enterprise Value is ¥2,005.7 Mil. Qinghai Spring Medicinal Resources Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥28.3 Mil. Therefore, Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF for today is 70.97.

The historical rank and industry rank for Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF or its related term are showing as below:

SHSE:600381' s EV-to-FCF Range Over the Past 10 Years
Min: -777.65   Med: -10.66   Max: 409.78
Current: 59.96

During the past 13 years, the highest EV-to-FCF of Qinghai Spring Medicinal Resources Technology Co was 409.78. The lowest was -777.65. And the median was -10.66.

SHSE:600381's EV-to-FCF is ranked worse than
76.63% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs SHSE:600381: 59.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), Qinghai Spring Medicinal Resources Technology Co's stock price is ¥3.64. Qinghai Spring Medicinal Resources Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.495. Therefore, Qinghai Spring Medicinal Resources Technology Co's PE Ratio (TTM) for today is At Loss.


Qinghai Spring Medicinal Resources Technology Co EV-to-FCF Historical Data

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qinghai Spring Medicinal Resources Technology Co EV-to-FCF Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.70 -17.57 -25.58 -216.34 422.30

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -328.98 422.30 58.49 17.84 58.65

Competitive Comparison of Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF falls into.



Qinghai Spring Medicinal Resources Technology Co EV-to-FCF Calculation

Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2005.699/28.26
=70.97

Qinghai Spring Medicinal Resources Technology Co's current Enterprise Value is ¥2,005.7 Mil.
Qinghai Spring Medicinal Resources Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥28.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qinghai Spring Medicinal Resources Technology Co  (SHSE:600381) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Qinghai Spring Medicinal Resources Technology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.64/-0.495
=At Loss

Qinghai Spring Medicinal Resources Technology Co's share price for today is ¥3.64.
Qinghai Spring Medicinal Resources Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.495.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Qinghai Spring Medicinal Resources Technology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Qinghai Spring Medicinal Resources Technology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Qinghai Spring Medicinal Resources Technology Co Business Description

Traded in Other Exchanges
N/A
Address
East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
Executives
Xiao Rong Director
Lu Yi Ping Director

Qinghai Spring Medicinal Resources Technology Co Headlines

No Headlines